Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Benjamin Goldstein

Pediatric Pulmonology Toledo, OH Medical Doctor

NPI 1861783680 CMS profile 2787129

2121 Hughes Dr Ste 640, Toledo, OH 43606

Open in the dashboard

General payments

$5,518

291 records reported · program years 2019–2025

Research payments

$2,057

Paid to them · 10 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$112,042 paid to institutions, not to them · program year 2025

Through program year 2025, Benjamin Goldstein of Toledo, OH is reported in the CMS Open Payments database as having received $5,518 across 291 general payments and $2,057 in research payments paid to them. Separately, studies naming them as principal investigator received $112,042 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 89th percentile of Pediatric Pulmonology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $996 51
2025 Research $2,057 10
2024 General $723 35
2023 General $656 35
2022 General $848 47
2021 General $905 52
2020 General $490 28
2019 General $901 43

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Benjamin Goldstein
  • Pediatric Pulmonology median
  • Middle half of Pediatric Pulmonology
  • National median

In program year 2025, general payments to Benjamin Goldstein were reported at $996. Among 622 Pediatric Pulmonology profiles paid that year, the median was $139 and the middle half received between $60 and $405.

Show as a table
Year Benjamin Goldstein Pediatric Pulmonology median Middle half National median
2019 $901 $151 $59–$495 $163
2020 $490 $107 $34–$339 $114
2021 $905 $125 $40–$511 $132
2022 $848 $133 $49–$428 $149
2023 $656 $138 $44–$494 $160
2024 $723 $132 $46–$398 $164
2025 $996 $139 $60–$405 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Vertex Pharmaceuticals Incorporated $1,287 65 payments
  2. AbbVie, Inc. $915 63 payments
  3. AstraZeneca Pharmaceuticals LP $596 34 payments
  4. Mylan Specialty L.P. $318 10 payments
  5. Regeneron Healthcare Solutions, Inc. $248 12 payments
  6. Gilead Sciences, Inc. $218 9 payments
  7. Insmed, Inc. $196 6 payments
  8. Chiesi USA, Inc. $196 11 payments
  9. Aimmune Therapeutics, Inc. $187 13 payments
  10. Advanced Respiratory, Inc $183 11 payments
  11. Other $1,175 57 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $5,402 289 payments
  2. Education $116 2 payments
Products named General payments · program years 2019–2025
  1. CREON $859 60 payments
  2. TRIKAFTA $376 21 payments
  3. TOBI Podhaler $296 8 payments
  4. ZENPEP $286 19 payments
  5. DUPIXENT Immunology $231 8 payments
  6. TEZSPIRE $220 10 payments
  7. FASENRA $193 12 payments
  8. Arikayce $178 5 payments
  9. DUPIXENT Inflammation And Immunology $168 8 payments
  10. PERTZYE $154 9 payments
  11. Other $2,175 108 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Teva Pharmaceuticals USA, Inc. $2,057 10 payments

Records

301 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record